MW
DMAC icon

Members Wealth’s DiaMedica Therapeutics DMAC Stock Holding History

Members Wealth’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$714K Hold
101,382
– – 0.39% 46
2026
Q1 		$656K Hold
101,382
– – 0.39% 48
2025
Q4 		$864K Buy
+101,382
New +$758K 0.54% 36

Other funds holding DMAC

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
CFP
Catalyst Financial Partners Boston, Massachusetts $1.01B AUM 36.54% 1-Year Est. Return
CWM
Cornerstone Wealth Management St. Peters, Missouri $2.33B AUM 25.21% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Members Wealth's DMAC Position: Q2 2026 in Review

Members Wealth held its DiaMedica Therapeutics (DMAC) position steady in Q2 2026 at 101,382 shares worth $714K. The position accounts for 0.39% of the portfolio, ranked #46.

Members Wealth first reported a position in DMAC in Q4 2025 and has held it in 3 quarters since. The position peaked at $864K in Q4 2025. 16 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • Members Wealth held 101,382 shares of DiaMedica Therapeutics worth $714K as of Q2 2026.
  • Members Wealth left its DiaMedica Therapeutics share count unchanged in Q2 2026.
  • DiaMedica Therapeutics made up 0.39% of Members Wealth's portfolio in Q2 2026, its #46 holding.
  • Members Wealth first reported a position in DiaMedica Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Members Wealth's DiaMedica Therapeutics position peaked at $864K in Q4 2025.
  • 16 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Members Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.